| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |